IMPACT OF SINUSITIS IN CYSTIC-FIBROSIS

被引:108
作者
RAMSEY, B
RICHARDSON, MA
机构
[1] CHILDRENS HOSP & MED CTR,DIV OTOLARYNGOL,SEATTLE,WA 98105
[2] UNIV WASHINGTON,SCH MED,DEPT PEDIAT,SEATTLE,WA 98195
[3] UNIV WASHINGTON,SCH MED,DEPT OTOLARYNGOL HEAD & NECK SURG,SEATTLE,WA 98195
关键词
SINUSITIS; CYSTIC FIBROSIS;
D O I
10.1016/0091-6749(92)90183-3
中图分类号
R392 [医学免疫学];
学科分类号
100102 ;
摘要
The cause of cystic fibrosis has been determined to be faulty ionic transport of chloride across the apical membrane of epithelial cells lining exocrine glands. The subnormal ionic transport leads to dehydration of extra cellular fluids and the development of thickened inspissated mucous secretions. The vast majority of patients with cystic fibrosis develop sinus disease with panopacification of the sinuses present in 90% to 100% of patients older than 8 months of age. Indications for surgical management of sinusitis in children with cystic fibrosis include (1) chronic nasal obstruction with mouth breathing, (2) chronic purulent draining nasal secretions unresponsive to medical treatment, and (3) persistent headaches thought to be related to sinusitis. Operative therapy is based on computerized tomographic scan findings and can be performed endoscopically. Postoperative management is critical for ensuring successful surgical results. Antibiotics, topical steroids, and cleansing of the surgical fields must be performed on a regular basis to ensure adequate healing. The impact of sinusitis on the cystic fibrosis population is significant. Approximately 20% of patients will eventually require surgical treatment of their sinuses. Chronic sinusitis may cause deformities of the external nasal skeleton, a loss of the sense of smell, and headaches.
引用
收藏
页码:547 / 552
页数:6
相关论文
共 50 条
  • [31] DNASE TRIALS IN CYSTIC-FIBROSIS
    HODSON, ME
    SHAH, PL
    EUROPEAN RESPIRATORY JOURNAL, 1995, 8 (10) : 1786 - 1791
  • [32] GASTROENTEROLOGICAL ASPECTS OF CYSTIC-FIBROSIS
    HEIJERMAN, HGM
    NETHERLANDS JOURNAL OF MEDICINE, 1992, 41 (3-4) : 93 - 96
  • [33] PROBENECID PHARMACOKINETICS IN CYSTIC-FIBROSIS
    WEBER, A
    DEGROOT, R
    RAMSEY, B
    WILLIAMSWARREN, J
    SMITH, A
    DEVELOPMENTAL PHARMACOLOGY AND THERAPEUTICS, 1991, 16 (01): : 7 - 12
  • [34] CYSTIC-FIBROSIS - THE NEW GENETICS
    BROCK, DJH
    SHRIMPTON, AE
    JONES, C
    MCINTOSH, I
    JOURNAL OF THE ROYAL SOCIETY OF MEDICINE, 1991, 84 : 2 - 6
  • [35] ABDOMINAL RADIOLOGY IN CYSTIC-FIBROSIS
    CARTY, H
    JOURNAL OF THE ROYAL SOCIETY OF MEDICINE, 1995, 88 : 18 - 23
  • [36] CYSTIC-FIBROSIS AND PHOSPHATIDYLCHOLINE BIOSYNTHESIS
    ULANE, MM
    BUTLER, JD
    PERI, A
    MIELE, L
    ULANE, RE
    HUBBARD, VS
    CLINICA CHIMICA ACTA, 1994, 230 (02) : 109 - 116
  • [37] BRONCHIAL HYPERREACTIVITY IN CYSTIC-FIBROSIS
    OSWALDMAMMOSSER, M
    DONATO, L
    VANDEVENNE, A
    KESSLER, R
    REVUE DES MALADIES RESPIRATOIRES, 1991, 8 (03) : 283 - 287
  • [38] MUCOCELE OF APPENDIX IN CYSTIC-FIBROSIS
    FUCHS, B
    BOHM, N
    MEDIZINISCHE WELT, 1991, 42 (03): : 223 - 225
  • [39] INHALATION OF ANTIBIOTICS IN CYSTIC-FIBROSIS
    TOUW, DJ
    BRIMICOMBE, RW
    HODSON, ME
    HEIJERMAN, HGM
    BAKKER, W
    EUROPEAN RESPIRATORY JOURNAL, 1995, 8 (09) : 1594 - 1604
  • [40] NONADHERENCE TO TREATMENT IN CYSTIC-FIBROSIS
    LASK, B
    JOURNAL OF THE ROYAL SOCIETY OF MEDICINE, 1994, 87 : 25 - 27